See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.84▲ 1.94%
← 0KRR page
XStocksXray
Market X-Ray report · 27 October 2026

Proto Labs, Inc. (0KRR)

London Stock Exchange · UK · prices in USD · close of 27 Oct 2026

Key indicators

Last closeUSD 89.72
52-week range50.21 – 102.90
Return, 1 month / 3 months−6.0% / +14.8%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)52
Volatility (1 year)44.1%
Worst drawdown (1 year)-18.9%
Average daily value traded0.02M USD
Dividend yield–

Market X-Ray price-based

66/ 100 · Medium confidence · ahead of 78% of stocks on this exchange
Trend84
Momentum88
Stability (higher is calmer)55
Liquidity16
Income–

Five-year price chart navy: price · brown: 200-day average

47.3360.7674.2087.631012025-122026-022026-052026-082026-10

About the company

Proto Labs is a manufacturer that helps product developers and engineers turn designs into physical parts quickly. Customers upload digital design files and receive machined, molded or additively manufactured components in small quantities, which suits prototyping and low-volume production. The company works with a wide range of industries that need custom parts without long tooling lead times. It is based in Maple Plain, Minnesota, in the United States.

Proto Labs, Inc. trades under the code 0KRR on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Proto Labs, Inc. (0KRR) trades on the London Stock Exchange in UK. It last closed at USD 89.72 on 27 October 2026.

Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 851 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Proto Labs, Inc. (0KRR)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average22.8%
From 52-week high-8.6%
Momentum88 · StrongRising faster than most stocks on this exchange.
3-month return14.8%
6-month return42.2%
12-month return, skipping the last month–
Stability (higher is calmer)55 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)44.1%
Worst drawdown, 1 year (smaller is calmer)-18.9%
Liquidity16 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.02M USD
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+2.2%
1 month−6.0%
3 months+14.8%
6 months+42.2%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average86.31 / 73.04
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.33

Technical summary

DailyBullish8 bullish · 4 neutral · 3 bearish
WeeklyStrongly bullish6 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026